Molecular Influenza Diagnostic Market - Global Outlook and Forecast 2023-2028

Report ID: 1567476 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Molecular Influenza Diagnostic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Molecular Influenza Diagnostic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Molecular Influenza Diagnostic Overall Market Size
    2.1 Global Molecular Influenza Diagnostic Market Size: 2021 VS 2028
    2.2 Global Molecular Influenza Diagnostic Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Molecular Influenza Diagnostic Players in Global Market
    3.2 Top Global Molecular Influenza Diagnostic Companies Ranked by Revenue
    3.3 Global Molecular Influenza Diagnostic Revenue by Companies
    3.4 Top 3 and Top 5 Molecular Influenza Diagnostic Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Molecular Influenza Diagnostic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Molecular Influenza Diagnostic Players in Global Market
        3.6.1 List of Global Tier 1 Molecular Influenza Diagnostic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Molecular Influenza Diagnostic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Molecular Influenza Diagnostic Market Size Markets, 2021 & 2028
        4.1.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
        4.1.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests
        4.1.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
        4.1.5 Simple Amplification-based Assays (SAMBA)
    4.2 By Type - Global Molecular Influenza Diagnostic Revenue & Forecasts
        4.2.1 By Type - Global Molecular Influenza Diagnostic Revenue, 2017-2022
        4.2.2 By Type - Global Molecular Influenza Diagnostic Revenue, 2023-2028
        4.2.3 By Type - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Molecular Influenza Diagnostic Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 POCT
        5.1.4 Others
    5.2 By Application - Global Molecular Influenza Diagnostic Revenue & Forecasts
        5.2.1 By Application - Global Molecular Influenza Diagnostic Revenue, 2017-2022
        5.2.2 By Application - Global Molecular Influenza Diagnostic Revenue, 2023-2028
        5.2.3 By Application - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Molecular Influenza Diagnostic Market Size, 2021 & 2028
    6.2 By Region - Global Molecular Influenza Diagnostic Revenue & Forecasts
        6.2.1 By Region - Global Molecular Influenza Diagnostic Revenue, 2017-2022
        6.2.2 By Region - Global Molecular Influenza Diagnostic Revenue, 2023-2028
        6.2.3 By Region - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Molecular Influenza Diagnostic Revenue, 2017-2028
        6.3.2 US Molecular Influenza Diagnostic Market Size, 2017-2028
        6.3.3 Canada Molecular Influenza Diagnostic Market Size, 2017-2028
        6.3.4 Mexico Molecular Influenza Diagnostic Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Molecular Influenza Diagnostic Revenue, 2017-2028
        6.4.2 Germany Molecular Influenza Diagnostic Market Size, 2017-2028
        6.4.3 France Molecular Influenza Diagnostic Market Size, 2017-2028
        6.4.4 U.K. Molecular Influenza Diagnostic Market Size, 2017-2028
        6.4.5 Italy Molecular Influenza Diagnostic Market Size, 2017-2028
        6.4.6 Russia Molecular Influenza Diagnostic Market Size, 2017-2028
        6.4.7 Nordic Countries Molecular Influenza Diagnostic Market Size, 2017-2028
        6.4.8 Benelux Molecular Influenza Diagnostic Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Molecular Influenza Diagnostic Revenue, 2017-2028
        6.5.2 China Molecular Influenza Diagnostic Market Size, 2017-2028
        6.5.3 Japan Molecular Influenza Diagnostic Market Size, 2017-2028
        6.5.4 South Korea Molecular Influenza Diagnostic Market Size, 2017-2028
        6.5.5 Southeast Asia Molecular Influenza Diagnostic Market Size, 2017-2028
        6.5.6 India Molecular Influenza Diagnostic Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Molecular Influenza Diagnostic Revenue, 2017-2028
        6.6.2 Brazil Molecular Influenza Diagnostic Market Size, 2017-2028
        6.6.3 Argentina Molecular Influenza Diagnostic Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue, 2017-2028
        6.7.2 Turkey Molecular Influenza Diagnostic Market Size, 2017-2028
        6.7.3 Israel Molecular Influenza Diagnostic Market Size, 2017-2028
        6.7.4 Saudi Arabia Molecular Influenza Diagnostic Market Size, 2017-2028
        6.7.5 UAE Molecular Influenza Diagnostic Market Size, 2017-2028
7 Players Profiles
    7.1 BD
        7.1.1 BD Corporate Summary
        7.1.2 BD Business Overview
        7.1.3 BD Molecular Influenza Diagnostic Major Product Offerings
        7.1.4 BD Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.1.5 BD Key News
    7.2 Abbott (Include Alere)
        7.2.1 Abbott (Include Alere) Corporate Summary
        7.2.2 Abbott (Include Alere) Business Overview
        7.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Major Product Offerings
        7.2.4 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.2.5 Abbott (Include Alere) Key News
    7.3 Roche
        7.3.1 Roche Corporate Summary
        7.3.2 Roche Business Overview
        7.3.3 Roche Molecular Influenza Diagnostic Major Product Offerings
        7.3.4 Roche Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.3.5 Roche Key News
    7.4 SIEMENS
        7.4.1 SIEMENS Corporate Summary
        7.4.2 SIEMENS Business Overview
        7.4.3 SIEMENS Molecular Influenza Diagnostic Major Product Offerings
        7.4.4 SIEMENS Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.4.5 SIEMENS Key News
    7.5 Analytik Jena
        7.5.1 Analytik Jena Corporate Summary
        7.5.2 Analytik Jena Business Overview
        7.5.3 Analytik Jena Molecular Influenza Diagnostic Major Product Offerings
        7.5.4 Analytik Jena Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.5.5 Analytik Jena Key News
    7.6 Quidel
        7.6.1 Quidel Corporate Summary
        7.6.2 Quidel Business Overview
        7.6.3 Quidel Molecular Influenza Diagnostic Major Product Offerings
        7.6.4 Quidel Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.6.5 Quidel Key News
    7.7 Thermo Fisher
        7.7.1 Thermo Fisher Corporate Summary
        7.7.2 Thermo Fisher Business Overview
        7.7.3 Thermo Fisher Molecular Influenza Diagnostic Major Product Offerings
        7.7.4 Thermo Fisher Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.7.5 Thermo Fisher Key News
    7.8 Meridian Bioscience
        7.8.1 Meridian Bioscience Corporate Summary
        7.8.2 Meridian Bioscience Business Overview
        7.8.3 Meridian Bioscience Molecular Influenza Diagnostic Major Product Offerings
        7.8.4 Meridian Bioscience Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.8.5 Meridian Bioscience Key News
    7.9 BioMerieux
        7.9.1 BioMerieux Corporate Summary
        7.9.2 BioMerieux Business Overview
        7.9.3 BioMerieux Molecular Influenza Diagnostic Major Product Offerings
        7.9.4 BioMerieux Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.9.5 BioMerieux Key News
    7.10 Sekisui Diagnostics
        7.10.1 Sekisui Diagnostics Corporate Summary
        7.10.2 Sekisui Diagnostics Business Overview
        7.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Major Product Offerings
        7.10.4 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.10.5 Sekisui Diagnostics Key News
    7.11 Response Biomedical
        7.11.1 Response Biomedical Corporate Summary
        7.11.2 Response Biomedical Business Overview
        7.11.3 Response Biomedical Molecular Influenza Diagnostic Major Product Offerings
        7.11.4 Response Biomedical Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.11.5 Response Biomedical Key News
    7.12 SA Scientific
        7.12.1 SA Scientific Corporate Summary
        7.12.2 SA Scientific Business Overview
        7.12.3 SA Scientific Molecular Influenza Diagnostic Major Product Offerings
        7.12.4 SA Scientific Molecular Influenza Diagnostic Revenue in Global Market (2017-2022)
        7.12.5 SA Scientific Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Molecular Influenza Diagnostic Market Opportunities & Trends in Global Market
    Table 2. Molecular Influenza Diagnostic Market Drivers in Global Market
    Table 3. Molecular Influenza Diagnostic Market Restraints in Global Market
    Table 4. Key Players of Molecular Influenza Diagnostic in Global Market
    Table 5. Top Molecular Influenza Diagnostic Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Molecular Influenza Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Molecular Influenza Diagnostic Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Molecular Influenza Diagnostic Product Type
    Table 9. List of Global Tier 1 Molecular Influenza Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Molecular Influenza Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Molecular Influenza Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Molecular Influenza Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Molecular Influenza Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Molecular Influenza Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Molecular Influenza Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Molecular Influenza Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Molecular Influenza Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Molecular Influenza Diagnostic Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Molecular Influenza Diagnostic Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 30. BD Corporate Summary
    Table 31. BD Molecular Influenza Diagnostic Product Offerings
    Table 32. BD Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 33. Abbott (Include Alere) Corporate Summary
    Table 34. Abbott (Include Alere) Molecular Influenza Diagnostic Product Offerings
    Table 35. Abbott (Include Alere) Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 36. Roche Corporate Summary
    Table 37. Roche Molecular Influenza Diagnostic Product Offerings
    Table 38. Roche Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 39. SIEMENS Corporate Summary
    Table 40. SIEMENS Molecular Influenza Diagnostic Product Offerings
    Table 41. SIEMENS Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 42. Analytik Jena Corporate Summary
    Table 43. Analytik Jena Molecular Influenza Diagnostic Product Offerings
    Table 44. Analytik Jena Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 45. Quidel Corporate Summary
    Table 46. Quidel Molecular Influenza Diagnostic Product Offerings
    Table 47. Quidel Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 48. Thermo Fisher Corporate Summary
    Table 49. Thermo Fisher Molecular Influenza Diagnostic Product Offerings
    Table 50. Thermo Fisher Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 51. Meridian Bioscience Corporate Summary
    Table 52. Meridian Bioscience Molecular Influenza Diagnostic Product Offerings
    Table 53. Meridian Bioscience Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 54. BioMerieux Corporate Summary
    Table 55. BioMerieux Molecular Influenza Diagnostic Product Offerings
    Table 56. BioMerieux Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 57. Sekisui Diagnostics Corporate Summary
    Table 58. Sekisui Diagnostics Molecular Influenza Diagnostic Product Offerings
    Table 59. Sekisui Diagnostics Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 60. Response Biomedical Corporate Summary
    Table 61. Response Biomedical Molecular Influenza Diagnostic Product Offerings
    Table 62. Response Biomedical Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 63. SA Scientific Corporate Summary
    Table 64. SA Scientific Molecular Influenza Diagnostic Product Offerings
    Table 65. SA Scientific Molecular Influenza Diagnostic Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Molecular Influenza Diagnostic Segment by Type in 2021
    Figure 2. Molecular Influenza Diagnostic Segment by Application in 2021
    Figure 3. Global Molecular Influenza Diagnostic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Molecular Influenza Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Molecular Influenza Diagnostic Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Molecular Influenza Diagnostic Revenue in 2021
    Figure 8. By Type - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    Figure 12. US Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    Figure 16. Germany Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 17. France Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    Figure 24. China Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 28. India Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    Figure 30. Brazil Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Molecular Influenza Diagnostic Revenue Market Share, 2017-2028
    Figure 33. Turkey Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Molecular Influenza Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 37. BD Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Abbott (Include Alere) Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Roche Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. SIEMENS Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Analytik Jena Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Quidel Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Thermo Fisher Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Meridian Bioscience Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. BioMerieux Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sekisui Diagnostics Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Response Biomedical Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. SA Scientific Molecular Influenza Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
60
Frequently Asked Questions
Molecular Influenza Diagnostic Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Molecular Influenza Diagnostic Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Molecular Influenza Diagnostic Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports